While the flagship South Korean KOSPI index is experiencing one of the deepest slumps in its history, a real rally is unfolding on the alternative KOSDAQ exchange. Shares of HLB, SPG, and Peptron have risen more than 50% over the past month, demonstrating impressive resilience and attracting the attention of investors seeking refuge from the turbulence in the blue-chip market.

KOSPI: A Month of Losses and Regulatory Measures

July proved catastrophic for the KOSPI, which plunged 22% — one of the largest monthly declines in the index's history. Since July 22, after updating record highs, the index has lost up to 34% of its value. Although a powerful one-day rebound of nearly 18% on the last trading day of the month somewhat softened the scale of losses, the overall picture remains extremely alarming.

The key trigger for the crash was regulators tightening trading rules for leveraged ETFs focused on the shares of tech giants Samsung Electronics and SK Hynix. The minimum cash deposit for operations with these instruments was raised from 10 million to 30 million won (KRW), leading to a 93% collapse in trading volumes. Instead of the expected stabilization, this triggered a capital shift: investors began massively withdrawing funds from KOSPI "heavyweights" and directing them toward smaller companies on KOSDAQ. The KOSDAQ index, in turn, showed growth for five consecutive trading sessions until August 6, ignoring the ongoing fluctuations of the main market.

Particularly painful for the market was the decline in memory manufacturer stocks. SK Hynix fell 14.65% on July 28, and Samsung Electronics dropped more than 13%. Investors fear that capital expenditures on artificial intelligence infrastructure have reached their peak. The 39% collapse in shares of American Micron only intensified pressure on South Korean chipmakers.

Three Success Stories on KOSDAQ

HLB — a pharmaceutical company developing the anticancer drug rivoceranib. On July 13, the FDA rejected approval for the third time, citing production issues at a Chinese partner's facility. However, the regulator lifted restrictions on the plant just two days later, triggering a surge in shares of nearly 30% in a single session.

SPG — a manufacturer of high-precision motors and reducers that is steadily growing thanks to an actuator project for humanoid robots. According to IBK Securities, it is the only Korean company with a full range of high-precision reducers for humanoid robots. SPG already supplies products to Rainbow Robotics and is conducting preliminary negotiations with American companies.

Peptron — rose on August 3 on rumors of possible participation in the supply chain of anti-obesity drugs. Investors believe Korean manufacturers will take on production for the domestic market of Eli Lilly's monthly GLP-1-based drug. An official supply contract has not yet been signed.

This market split is a vivid example of how regulatory intervention and a shift in narrative can radically change the structure of capital flows. While large institutional players flee the overheated AI sector, retail investors are finding new opportunities in niche growth stories. However, it is worth remembering: in conditions of high volatility, such rallies often prove short-lived, and the fundamental indicators of these companies require careful scrutiny before betting on a continuation of the trend.